Miller Joseph M (CIK 0001746372)

Latest company ownership

Shares held
124,393
Last filed at
Mar 4, 2025
Confidence Score
50.6
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
20,239
Last filed at
Apr 4, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2019Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 28, 2025 Mar 4, 2025 Aurinia Pharmaceuticals Inc. CFO Sell 97.5 +78,155 15.66% ✗ $939.6K
Mar 6, 2024 Mar 7, 2024 Aurinia Pharmaceuticals Inc. CFO Sell 42.5 -34,811 -6.56% ✗ $194.9K
Mar 2, 2023 Feb 22, 2024 Aurinia Pharmaceuticals Inc. CFO Sell 42.5 -11,398 -3.33% ✗ $100.1K
Mar 2, 2023 Mar 6, 2023 Aurinia Pharmaceuticals Inc. CFO Sell 95.0 +218,125 192.88% ✗ $101K
Mar 2, 2022 Mar 4, 2022 Aurinia Pharmaceuticals Inc. CFO Sell 91.3 +5,440 464.96% ✗ $36.8K
May 11, 2021 May 11, 2021 Aurinia Pharmaceuticals Inc. CFO Buy 90.0 +1,000 100.00% ✗ $9.7K
Jun 8, 2020 Jun 11, 2020 Avalo Therapeutics, Inc. Director Sell 26.3 -4,472 -9.93% ✗ $14.4K
Jun 7, 2019 Apr 13, 2020 Avalo Therapeutics, Inc. CFO Sell 26.3 -3,723 -7.63% ✗ $18.1K
Dec 10, 2019 Dec 11, 2019 Avalo Therapeutics, Inc. CFO Buy 85.0 +2,598 5.63% ✗ $7.4K
Jun 10, 2019 Jun 11, 2019 Avalo Therapeutics, Inc. CFO Buy 82.5 +1,179 2.62% ✗ $3.4K